Cargando…
A Prospective Study to Detect Immune Checkpoint Inhibitors Associated With Myocarditis Among Patients Treated for Lung Cancer
BACKGROUND: Immune checkpoint inhibitors (ICIs) are widely used in lung cancer management. However, myocarditis, which is a rare, yet potentially severe adverse-related event associated with ICIs, could be under-reported. OBJECTIVES: This study is aimed to prospectively evaluate the cumulative incid...
Autores principales: | Faubry, Clara, Faure, Maxime, Toublanc, Anne-Claire, Veillon, Rémi, Lemaître, Anne-Iris, Vergnenègre, Charlotte, Cochet, Hubert, Khan, Sadia, Raherison, Chantal, Dos Santos, Pierre, Zysman, Maeva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207328/ https://www.ncbi.nlm.nih.gov/pubmed/35734278 http://dx.doi.org/10.3389/fcvm.2022.878211 |
Ejemplares similares
-
Second‐line lurbinectedin as a new treatment option for small‐cell lung cancer: Preliminary results in real‐clinical practice
por: Toublanc, Anne‐Claire, et al.
Publicado: (2022) -
Effect of prior immunotherapy on the efficacy of chemotherapy in advanced non‐small cell lung cancer: A retrospective study
por: Heraudet, Luc, et al.
Publicado: (2022) -
Women's COPD
por: Zysman, Maéva, et al.
Publicado: (2022) -
Role of mitochondrial metabolism in immune checkpoint inhibitors-related myocarditis
por: Zhang, Xin, et al.
Publicado: (2023) -
Neutrophil-to-lymphocyte ratio evolution is an independent predictor of early progression of second-line nivolumab-treated patients with advanced non-small-cell lung cancers
por: Dusselier, Matthieu, et al.
Publicado: (2019)